| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V113349 | (Rac)-Emtricitabine S-oxide | 2733287-29-9 | (Rac)-Emtricitabine S-oxide ((Rac)-Emtricitabine sulfoxide; (Rac)-Emtricitabine degradation product-III) is a racemic mixture of emtricitabine S-oxide. |
|
V101476 | 12-Methoxydodecanoic acid | 92169-28-3 | 12-Methoxydodecanoic acid is a heteroatom-containing myristic acid analogue with anti-HIV activity with IC50 of 6.8 μM. |
|
V88714 | 2'-Deoxy-2'-fluoroarabinoadenosine | 20227-41-2 | 2'-Deoxy-2'-fluoroarabinoadenosine is a nucleoside analog with antiviral activity against human immunodeficiency virus (HIV). |
|
V107844 | 2,4-Dihydroxypyridine | 626-03-9 | 2,4-Dihydroxypyridine (Compound 2) is a pyridine derivative that has inhibitory activity against both Topo IIKHIV activity and HIV-1 replication, with pIC50 values of 5.05 and 4.07 for Topo IIKHIV and HIV-1 replication, respectively. |
|
V77253 | Anti-Mouse CD4 Antibody (YTS 191) | Anti-Mouse CD4 Antibody (YTS 191) is an anti-mouse CD4 IgG2b antibody inhibitor, and the host is Rat. | |
|
V53388 | APOBEC3G-IN-1 | 14261-92-8 | APOBEC3G-IN-1 (MN136.0185) is a potent HIV inhibitor targeting APOBEC3G. |
|
V3601 | Bevirimat | 174022-42-5 | Bevirimat (formerly known as PA-457, MPC-4326 and YK FH312), an analog of betulinic acid, is a novel and potent anti-HIV drug that acts as a maturation inhibitor. |
|
V1839 | BMS-378806 | 357263-13-9 | BMS-378806 (also known as BMS 806)is a novel, potent, orally bioavailable small molecule thatselectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in HIV virus. |
|
V54293 | BNM-III-170 | 1859189-55-1 | BNM-III-170 can inhibit HIV-1 from entering target cells. |
|
V76071 | Calcium mesoxalate (Ketomalonic acid calcium; Mesoxalic acid calcium; Oxomalonic acid calcium) | 21085-60-9 | Calcium mesoxalate blocks HIV-1 reverse transcriptase (HIV-1 RT) with IC50 of 2.2 μM. |
|
V78974 | Cys(Npys)-TAT (47-57) | Cys(Npys)-TAT (47-57) is a bioactive peptide segment of the TAT polypeptide that can form electrostatic interactions with plasmid DNA. | |
|
V35046 | Ditiocarb (Diethyldithiocarbamic acid) | 147-84-2 | Ditiocarb (Diethyldithiocarbamic acid) is a copper reagent that reacts with Cu2+ solution to form a complex, which increases the copper replacement precipitation rate. |
|
V52164 | Dolutegravir sodium (Dolutegravir sodium; S/GSK1349572 sodium) | 1051375-19-9 | Dolutegravir sodium (S/GSK1349572 sodium) is a potent, oral HIV integrase strand transfer inhibitor (antagonist) with IC50 of 2.7 nM in HIV-1 integrase-catalyzed strand transfer. |
|
V135812 | FC-14369 | 3066894-28-5 | FC-14369 is a PROTAC degrader targeting the HIV-1 Nef protein, with a DC50 value of 160 nM. |
|
V119605 | FITC-LC-TAT (47-57) acetate | FITC-LC-TAT (47-57) acetate is a FITC-labeled TAT peptide. | |
|
V54278 | GS-9822 | 2219362-41-9 | GS-9822 is a potent antiviral compound against wild-type HIV-1 virus with nanomolar activity. |
|
V137352 | HGS101 | HGS101 is a fully human CCR5 monoclonal antibody with high affinity for CCR5. | |
|
V101784 | HIV capsid modulator 2 | HIV capsid regulator 2 (compound 7t) is a regulator of HIV capsid protein (CA). | |
|
V54246 | HIV-1 inhibitor-10 | 1449660-81-4 | HIV-1 inhibitor-10 is a nanomolar inhibitor of HIV-1 maturation. |
|
V54263 | HIV-1 inhibitor-51 | 2834087-82-8 | HIV-1 inhibitor-51 is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that displays excellent antiviral effect against WT HIV-1 (IIIB) and a panel of mutant strains. |